Trial · NCT03806452
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients Achieving at Least a 30% Decrease in ACR Baseline Value | Hydroxycarbamide | 18 | Participants | ||
| Number of Patients Achieving at Least a 30% Decrease in ACR Baseline Value | Placebo | 15 | Participants | ||
| Absolute Mean Changes in eGFR Value | Hydroxycarbamide | 3.2 | Standard Deviation 18.5 | ml/min/1.73m2 | |
| Absolute Mean Changes in eGFR Value | Placebo | -1.0 | Standard Deviation 13.8 | ml/min/1.73m2 | |
| Absolute Mean Changes in ACR Value | Hydroxycarbamide | 3.5 | Standard Error 19.7 | mg/mmol | |
| Absolute Mean Changes in ACR Value | Placebo | 1.0 | Standard Error 13.1 | mg/mmol | |
| Proportion of Patients With a Shift From Macroalbuminuria to Microalbuminuria | Hydroxycarbamide | 1 | Participants | ||
| Proportion of Patients With a Shift From Macroalbuminuria to Microalbuminuria | Placebo | 2 | Participants | ||
| Proportion of Patients With a Shift From Microalbuminuria to Normoalbuminuria | Hydroxycarbamide | 10 | Participants | ||
| Proportion of Patients With a Shift From Microalbuminuria to Normoalbuminuria | Placebo | 7 | Participants | ||
| Proportion of Patients With a Shift From Macroalbuminuria to Normoalbuminuria | Hydroxycarbamide | 1 | Participants | ||
| Proportion of Patients With a Shift From Macroalbuminuria to Normoalbuminuria | Placebo | 0 | Participants | ||
| Proportion of Patients With a Shift From Microalbuminuria to Macroalbuminuria | Hydroxycarbamide | 3 | Participants | ||
| Proportion of Patients With a Shift From Microalbuminuria to Macroalbuminuria | Placebo | 3 | Participants | ||
| Absolute Mean Changes of Systolic Blood Pressure | Hydroxycarbamide | 2.8 | Standard Deviation 10.7 | mmHg | |
| Absolute Mean Changes of Systolic Blood Pressure | Placebo | 2.2 | Standard Deviation 13.1 | mmHg | |
| Absolute Mean Changes of Body Weight | Hydroxycarbamide | 2.2 | Standard Deviation 3.0 | kg | |
| Absolute Mean Changes of Body Weight | Placebo | -0.3 | Standard Deviation 2.1 | kg | |
| Absolute Mean Changes of Diastolic Blood Pressure | Hydroxycarbamide | 2.5 | Standard Deviation 13.3 | mmHg | |
| Absolute Mean Changes of Diastolic Blood Pressure | Placebo | -1.0 | Standard Deviation 12.9 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03806452/results